# Korean Researchers Develop AI to Predict Cancer Patients’ Response to Immunotherapy

A research team whose leadership is based in South Korea has developed an AI model for predicting how cancer patients will respond to immunotherapy. Designed to improve the precision of treatment in colorectal and gastric cancer, the AI model could provide physicians with a significantly more accurate tool for customizing therapies.

 As more such advances are made and enterprises like Calidi Biotherapeutics Inc. (NYSE American: CLDI) continue to make progress in their efforts to…

 Read More>>

 About TinyGems

 TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.TinyGems.com

 Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

 TinyGemsLos Angeles, CAwww.TinyGems.com310.299.1717 Office 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/tg/korean-researchers-develop-ai-to-predict-cancer-patients-response-to-immunotherapy/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/south-korean-team-develops-ai-model-for-predicting-cancer-patients-immunotherapy-response/7d7191b29f66d6bd36d9b8d529ac77a3) 


Pickup - [advos.io](https://advos.io/en/south-korean-researchers-develop-ai-to-enhance-cancer-treatment-precision/202514854)

Pickup - [newsworthy.ai](https://newsworthy.ai/curated/ai-model-promises-precision-in-cancer-immunotherapy-treatment-selection/202514854)

Pickup - [fishervista.com](https://fishervista.com/en/ai-model-breakthrough-predicting-cancer-treatment-response-with-unprecedented-accuracy/202514854)

Pickup - [hrmarketer.com](https://hrmarketer.com/en/ai-model-promises-precision-in-cancer-immunotherapy-treatment-selection/202514854)

Pickup - [citybuzz.co](https://citybuzz.co/ai-model-promises-more-precise-cancer-immunotherapy-predictions)

Pickup - [boostify.news](https://boostify.news/en/korean-researchers-develop-ai-model-to-enhance-cancer-immunotherapy-precision/202514854)

Pickup - [newswriter.ai](https://newswriter.ai/en/korean-researchers-develop-ai-model-to-enhance-cancer-treatment-prediction/202514854)

Pickup - [enhancedpr.com](https://enhancedpr.com/en/ai-breakthrough-korean-researchers-develop-predictive-model-for-cancer-immunotherapy-response/202514854)
 



[Reddit Post](https://www.reddit.com/r/HealthCareNewsInfo/comments/1l1ly9s/south_korean_team_develops_ai_model_for/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/256/2/openg6Uw.webp)